King Abdullah Medical City   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Makkah Saudi Arabia (2010)

Organization Overview

First Clinical Trial
2013
NCT02882776
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Jordan University of Science & Technology & King Abdullah University Hospital | King Abdullah International Medical Research Center | King Abdullah Medical City Makkah | King Abdullah Medical research Center - King Abdulaziz Medical City - Riyadh | King Abdullah University Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chronic Disease (Phase 1)

Coronavirus Infections (Phase 1)

Critical Illness (Phase 3)

Dyspepsia (Phase 2)

Gastritis (Phase 2)

Hodgkin Disease (Phase 2)

Lymphoma (Phase 2)

Sinusitis (Phase 1)

Syndrome (Phase 1)

Vitamin D Deficiency (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 17
  • # of Trial APIs: 28